Internal Medicine

An NIH-funded analysis of the Jackson Heart Study is diving deeper into the impact of smoking on African Americans.

A new study from the University of Arizona is shedding light on the psychological impact of Tai Chi in patients with cardiovascular disease.

Recent studies show efficacy and safety for both lemborexant and ozanimod.

Study investigators have completed what they call the most comprehensive characterization of elementary school-age concussions to date.

A new paper highlights the means by which child healthcare, a "human science," will rebound from the pandemic.

A new observational analysis from the University of Mississippi Medical Center is disputing the notion marijuana use increases stroke risk.

The most recent protests to police brutality, and the ensuing violence across cities and towns, sparked response from most national medical institutions—who for decades have sought to address disparities in care.

A new retrospective chart review is examining effectiveness of nitrous oxide during labor and potential predictors to conversion to other therapies.

A new Canadian Thoracic Society guidance sets recommendations for continued or halted use of inhaled steroids, nebulizers, biologics, and more.

New research from Nutrition Live Online 2020 is diving into the impact of high and low quality carbohydrates on diabetes risk.

Rituximab should be the gold-standard treatment.

In recent years, ustekinumab and tofacitinib have both been effective in treating ulcerative colitis.

An analysis of claims data from 2018 finds spending on diabetes-related supplies is greater than that of insulin, which accounts for nearly 20% of out-of-pocket healthcare spending.

More prospective studies are needed to examine how different drugs can be effective for schizophrenia patients based on the cluster of symptoms.

Guidelines are needed to better understand who needs the test.

A new systematic review and meta-analysis is shedding light on the potential impact of inadequate health literacy on mortality and hospitalizations in heart failure patients.

Antipsychotic discontinuation remains a major hurdle for effective schizophrenia treatment.

Younger patients with sickle cell disease report more positive experiences in the emergency department than older patients.

The tau tracer can support a pathological diagnosis of Alzheimer disease by identifying the underlying presence of NFTs at the B3 level.

The results of a phase 3B study show the medication is effective treating the disorder despite only needing to be taken once every 8 weeks.

Researchers are continuing to learn how the COVID-19 virus will effect patients with inflammatory bowel disease.

Discussing the results of a recent analysis that estimated the impact of comprehensive therapy with SGLT2 inhibitors, ARNIs, and MRAs in patients with HFrEF.

In a new study, investigators discover insomnia severity could predict first-onset major depressive disorder.

The latest scientific statement from the American Heart Association examines disparities in risk factors, social determinants of health, and management approaches for these patients.

Discussing the impact of COVID-19 on patients with neurologic conditions and how the rapid advent of telehealth has impacted interdisciplinary teams.